© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Nov 21, 2015, the consensus forecast amongst 30 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 24 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,445, with a high estimate of 1,800 and a low estimate of 1,218. The median estimate represents a 5.82% increase from the last price of 1,365.5. View Full Financials
In 2014, GlaxoSmithKline PLC reported a dividend of 0.80 GBP, which represents a 2.56% increase over last year. The 24 analysts covering the company expect dividends of 0.92 GBP for the upcoming fiscal year, an increase of 15.50%. View Full Financials
|Div growth (TTM)||+2.56 %|
On Oct 28, 2015, GlaxoSmithKline plc reported 3rd quarter 2015 earnings of 0.23 per share. This result exceeded the 0.19 consensus of the 10 analysts covering the company and under-performed last year's 3rd quarter results by 17.56 %.
The next earnings announcement is expected on Feb 03, 2016. View Full Interim Financials
|Average growth rate||-2.38 %|
GlaxoSmithKline plc reported annual 2014 earnings of 0.954 per share on Feb 04, 2015.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 03, 2016. View Full Annual Financials
|Average growth rate||-7.49 %|
GlaxoSmithKline plc had 3rd quarter 2015 revenues of 6.13bn. This bettered the 6.08bn consensus of the 10 analysts covering the company. This was 8.52% above the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||+2.31 %|
GlaxoSmithKline plc had revenues for the full year 2014 of 23.01bn. This was 13.20 % below the prior year's results. View Full Annual Financials
|Average growth rate||-4.99 %|